Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
Anticancer Research|December 1, 2022
Evaluation of Lung Toxicity With Lenalidomide Using the Pharmacovigilance DatabaseJunya Sato, Tsuchiya Eren, Saeko Murata, et al.
Oncology|August 20, 2023
Evaluation of Time to Onset and Outcome of Cardiac Adverse Events Associated with Nilotinib using Post-Marketing SurveillanceYuko Kanbayashi, Asuka Kojima, Haruka Wakabayashi, et al.
In Vivo (Athens, Greece)|January 2, 2023
The Influence of the Rapid Increase in the Number of Adverse Event Reports for COVID-19 Vaccine on the Disproportionality Analysis Using JADERKenta Yamaoka, Masaki Fujiwara, Mayako Uchida, et al.
In Vivo (Athens, Greece)|April 27, 2023
Evaluation of the Time to Onset and Outcome of Lenalidomide-induced Thrombosis and Embolism Using Spontaneous Reporting DatabaseJunya Sato, Naru Yamamoto, Yuka Kawahara, et al.
Journal of Clinical Pharmacy and Therapeutics|March 22, 2022
Comprehensive analysis of everolimus-induced adverse events using the Japanese real-world databaseMayako Uchida, Kana Nakano, Masaki Fujiwara, et al.
JCO Oncology Practice|June 10, 2025
Comprehensive Analysis of Detection Triggers for Immune-Related Adverse Events: Implications for Patient Education and ManagementHaruna Minami, Ryosuke Matsukane, Sai Yasukochi, et al.
Medical Oncology (Northwood, London, England)|September 29, 2022
Evaluation of lung adverse events with trastuzumab using the Japanese pharmacovigilance databaseYuko Kanbayashi, Mayako Uchida, Misui Kashiwagi, et al.
Scientific Reports|September 16, 2022
Evaluation of lung toxicity with bevacizumab using the spontaneous reporting databaseYuko Kanbayashi, Mayako Uchida, Misui Kashiwagi, et al.
In Vivo (Athens, Greece)|March 7, 2023
Assessment of Time-to-onset and Outcome of Lung Adverse Events With Pomalidomide from a Pharmacovigilance StudyYuka Kawahara, Saeko Murata, Tadashi Shimizu, et al.
Oncology|August 17, 2023
Evaluation of Time to Onset and Outcome of Lung Adverse Events Related to Pembrolizumab Using Marketing SurveillanceYuko Kanbayashi, Momoko Kobayashi, Miku Anzai, et al.
Pageof 11